# Determination of sample stability for a broad panel of coagulation parameters and factor assays on the Cobas t 711 analyzer starting from fresh-never-frozen plasma

**Authors:** Michael Hoffmann, Norbert Gottschalk, Philipp Huber, Vanessa Scheling, Nicole von Allmen, J. Kolja Hegel

PMC · DOI: 10.3389/fmolb.2025.1491239 · 2025-04-03

## TL;DR

This study tested how long coagulation test results remain stable under different storage conditions using the Cobas t 711 analyzer.

## Contribution

The study provides validated stability data for 23 coagulation assays under various storage conditions for routine testing.

## Key findings

- Sample stability met or exceeded requirements for all 23 assays under tested storage conditions.
- Fresh-never-frozen samples enabled early detection of out-of-specification results in real-life settings.
- Storage at 18–25°C, 2–8°C, or freezing conditions were evaluated for each assay.

## Abstract

Preanalytical procedures can affect the accuracy of coagulation assay results. Recommended plasma storage temperatures and durations need to be defined for individual coagulation assays. Here, we evaluated the effect of commonly applied plasma storage conditions for a broad panel of 23 basic coagulation parameters as well as specialized factor assays developed for the Cobas® t 711 analyzer (Roche Diagnostics International Ltd., Rotkreuz, Switzerland).

This single-center, prospective, observational study used anonymized, residual, platelet-poor plasma samples as well as pseudonymized plasma samples to obtain rare ranges of certain analytes. Fresh-never-frozen plasma samples processed within 4 h were tested in triplicate at time zero (t0), with measurements repeated at various predefined timepoints after storage at 18–25°C, 2–8°C, or under freezing and deep freezing. Mean deviation from t0, expressed as a percentage or as absolute change in signal at very low analyte levels, was assessed against predefined, assay-specific acceptance criteria for each analyte.

The sample stability results under the examined storage conditions for all 23 assays met or exceeded the requirements for routine laboratory coagulation testing and the respective acceptance criteria for each individual assay were fulfilled. Fresh-never-frozen samples were used to reflect real-life laboratory settings, enabling the early detection of out-of-specification results.

Sample stability was determined for a broad panel of assays on the t 711 analyzer, for application in routine coagulation testing practice.

## Full-text entities

- **Genes:** F13A1 (coagulation factor XIII A chain) [NCBI Gene 2162] {aka F13A}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, PROC (protein C, inactivator of coagulation factors Va and VIIIa) [NCBI Gene 5624] {aka APC, PC, PROC1, THPH3, THPH4}, SERPINC1 (serpin family C member 1) [NCBI Gene 462] {aka AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, DDI2 (DDI proteasomal shuttling factor 2) [NCBI Gene 84301] {aka RSC1A1}
- **Diseases:** lupus (MESH:D008180), coagulation abnormalities (MESH:D001778), hemolytic (MESH:D006461)
- **Chemicals:** acetyl salicylic acid (MESH:D001241), oral anticoagulants (-), marcumar (MESH:D010644), warfarin (MESH:D014859), sodium citrate (MESH:D000077559)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12003954